Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Condition: Head Lice InfestationIntervention: Drug: Abametapir Lotion 0.74% w/wSponsors: Hatchtech Pty Ltd; Accelovance Inc.; INC Research, LLCRecruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2014 Category: Research Source Type: clinical trials
A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
Condition: Head Lice InfestationIntervention: Drug: Ha44 Gel 0.74% w/wSponsor: Hatchtech Pty LtdCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2013 Category: Research Source Type: clinical trials
Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation
Condition: Head Lice InfestationIntervention: Drug: Ha44 GelSponsors: Hatchtech Pty Ltd; Accelovance; Target Health Inc.Completed - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2013 Category: Research Source Type: clinical trials
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
Condition: PediculosisInterventions: Drug: Malathion gel 0.5%; Drug: Permethrin 1% rinse (Nix Crème)Sponsor: Taro Pharmaceuticals USACompleted - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2009 Category: Research Source Type: clinical trials
